Overview:
This symposium has two principal aims: (1) to provide
guidance for new or inexperienced sites on how to establish
an effective IMR program and (2) to address controversies in
the field. We will specifically tackle what the ideal field
strength is for iMRI sites and openly discuss the necessity
of real time MR guidance versus efficient use of previously
acquired or iterative intra-procedure MR data. This
discussion will focus on cardiac EP ablations. |
| |
|
|
Agenda: |
|
| 18:15 |
Administrative Business |
|
18:30 |
Running an iMRI program: How We Do It (15-minutes
presentations)
Thermal – R. Jason Stafford, Ph.D., University of Texas M.D.
Anderson Cancer Center, Houston, TX, USA
Neuro – Charles L. Truwit, M.D., University of Minnesota,
Minneapolis, MN, USA |
|
19:00 |
Controversies in iMRI – Optimal Field Strength for IMR
(3 10-minute “position statements”, 15 min panel discussion)
1T Advocate – Ulf Teichgräber, M.D., Charité -
Universitätsmedizin Berlin, Berlin, Germany
1.5T Advocate – Clifford R. Weiss, M.D., Johns Hopkins
University, Baltimore, MD, USA
3T Advocate – Clare Tempany, M.D., /Kemal Tuncali,
Brigham and Women’s Hospital, Boston, MA, USA |
|
19:45 |
Controversies in iMRI – MR Guided versus MR Assisted for
Cardiac EP
(2 10-minute “position statements”, 10 min panel discussion)
MR Guided Advocate – Graham A. Wright, Ph.D.,
University of Toronto, Toronto, ON, Canada
MR Assisted Advocate – Tobias R. Schaeffter, Ph.D., Kings
College London, London, UK |
| 20:15 |
Adjourn |
| |
|
|
